The injectable tracer, Flyrcado, could help doctors flag deadly coronary artery disease in patients during imaging tests.

The U.S. Food and Drug Administration approved GE HealthCare's diagnostic drug for use in detection of coronary artery ...

The following is a summary of “Comparison of liberal versus restrictive transfusion strategies after hip surgery in patients ...

GEHC's Flyrcado, a first-of-its-kind PET tracer for coronary artery disease, receives FDA approval, expanding diagnostic access and improving patient outcomes.

In the continuous quest for medical breakthroughs, an international consortium of scientists made a groundbreaking discovery ...

It is expected to improve access to PET MPI, particularly for patients who are challenging to image, such as those with a ...

Heart disease is one of the leading causes of death worldwide, yet many of its risk factors are within your control. By ...

Physician-scientists from the University of Alabama at Birmingham Marnix E. Heersink School of Medicine have new insights ...

A study carried out at Mount Sinaí Fuster Heart Hospital in New York in collaboration with the Centro Nacional de ...

High cholesterol and microplastics are emerging as extremely dangerous risk factors for cardiovascular diseases, like heart ...